Aarti Drugs Limited — Important, 24-10-2024: Financial Result Updates

Aarti Drugs Limited reported its audited standalone and consolidated financial results for the quarter and half-year ended September 30, 2024. The Board approved these results with total income significantly increasing, accompanied by a notable profit before tax. The company successfully completed a buyback of 6,65,000 equity shares, totaling Rs. 59.85 crore. Key financial documents, including the assets and liabilities statement and cash flow statement, will be published for investor review.